NCT00380211View on ClinicalTrials.gov

Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

November 30, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza vaccine (A/H3N2, A/H1N1, and B strains)

BIOLOGICAL

Fluarix

Trial Locations (6)

13901

GSK Investigational Site, Binghamton

22015

GSK Investigational Site, Burke

33173

GSK Investigational Site, Miami

66219

GSK Investigational Site, Lenexa

76135

GSK Investigational Site, Fort Worth

78705

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY